VitaDAO has raised $4.1 million from Pfizer Ventures among other investors. The latest fund raiser will fund longevity research projects and the development of its first biotech startup. VitaDAO has raised $4.1 million from Pfizer Ventures among other investors. The decentralized autonomous organization (DAO) focuses on raising funds for human life extension research. Pharmaceutical giant Pfizer
